The Mexico medical cannabis market size is expected to reach USD 249.6 million by 2025, exhibiting a CAGR 27.7% over the forecast period, according to a new report by Grand View Research, Inc. Rising adoption of medicinal marijuana for the treatment of chronic conditions such as Alzheimer's disease, cancer, arthritis, anxiety, and epilepsy is one of the key factors propelling the Mexican medical cannabis market. Furthermore, approval of CBD derivatives for medicinal use is also expected to drive demand in the coming years. The cannabis industry is booming due to its increasing adoption for medicinal application and imminent legalization for recreational use. In Mexico, marijuana is only legalized for medicinal use and is anticipated to be legalized for recreational purposes in an effort to abolish illicit drug trade and generate tax revenue. Competition among existing players is moderately high as very few companies have the technology, financial resources, and legal clearance to venture into large-scale manufacturing of marijuana. Medical marijuana has been legalized in Mexico since June 2017. Health licenses for cultivation, harvesting, and production of marijuana in the country are exclusively limited to medicinal and research purposes. Laws pertaining to marijuana are not that well-regulated in the nation and go through a secondary regulation by Federal Commission for the Protection against Health Risks. Further key findings from the report suggest: • In 2018, buds held the largest revenue share accounting for 47.4% owing to easy availability and low price as compared to cannabis extracts • Cannabis oil is anticipated to emerge as the fastest growing segment, expanding at a CAGR of 33.1% between 2019 and 2025 • Chronic pain held the largest revenue share based on application, owing to rapid adoption of marijuana for the treatment of chronic pain as an alternative to opioids and synthetic drugs • Key players in this space include Aurora Cannabis; GW Pharmaceuticals plc.; Canopy Growth Corporation; HempMeds; CV Sciences Inc.; Endoca; Isodiol International Inc.; CBD Life; Pharmacielo; CBD American Shaman; and Elixinol.
Table of Contents Chapter 1 Methodology and Scope 1.1 Research Methodology 1.2 Research Scope and Assumptions 1.3 List to Data Sources Chapter 2 Executive Summary 2.1 Market Outlook Chapter 3 Mexico Medical Cannabis Market Variables, Trends & Scope 3.1 Market Segmentation 3.2 Mexico Medical Cannabis Market Dynamics 3.2.1 Market Driver Analysis 184.108.40.206 Growing adoption of medical cannabis for treatment of chronic diseases 220.127.116.11 Impending legalization of cannabis for recreational use 3.2.2 Market Restraint Analysis 18.104.22.168 Lower market access of cannabis due to absence of legalization programs leading to illegal smugglings 3.3 Penetration & Growth Prospects Mapping 3.4 Global Legal Cannabis Trade Route 3.5 Global Legal Cannabis Demand and Supply Analysis 3.6 Mexico Medical Cannabis Market Analysis Tools 3.6.1 Mexico Medical Cannabis Market - PESTLE Analysis 22.214.171.124 Political & Legal Landscape 126.96.36.199 Environmental Landscape 188.8.131.52 Social Landscape 184.108.40.206 Technology Landscape 3.6.2 Industry Analysis - Porter's 220.127.116.11 Supplier Power: Moderate 18.104.22.168 Buyer Power: Low 22.214.171.124 Substitution Threat: Low 126.96.36.199 Threat from New Entrants: Moderate 188.8.131.52 Competitive Rivalry: Moderately High 3.6.3 Regulatory Scenario 3.6.4 Mexico Cannabis Business Trends 3.6.5 Opportunity Analysis 3.6.6 Patient Pool Analysis (Estimates & Trends) Chapter 4 Mexico Medical Cannabis Market: Product Type Estimates & Trend Analysis 4.1 Mexico Medical Cannabis Market: Product Type Movement Analysis 4.2 Buds 4.2.1 Buds Market Estimates and Forecasts, 2014 - 2025 (USD Million) 4.3 Oils 4.3.1 Oils Market Estimates and Forecasts, 2014 - 2025 (USD Million) 4.4 Tinctures 4.4.1 Tinctures Market Estimates and Forecasts, 2014 - 2025 (USD Million) Chapter 5 Mexico Medical Cannabis Market: Medical Application Estimates & Trend Analysis 5.1 Mexico Medical Cannabis Market: Medical Application Movement Analysis 5.2 Chronic Pain 5.2.1 Chronic Pain Market Estimates and Forecasts, 2014 - 2025 (USD Million) 5.3 Mental Disorders 5.3.1 Mental Disorders Market Estimates and Forecasts, 2014 - 2025 (USD Million) 5.4 Cancer 5.4.1 Cancer Market Estimates and Forecasts, 2014 - 2025 (USD Million) 5.5 Others 5.5.1 Others Market Estimates and Forecasts, 2014 - 2025 (USD Million) Chapter 6 Competitive Landscape 6.1 Company Profiles 6.1.1 Aurora Cannabis 184.108.40.206 Company overview 220.127.116.11 Financial performance 18.104.22.168 Strategic initiatives 6.1.2 GW Pharmaceuticals, plc. 22.214.171.124 Company overview 126.96.36.199 Financial performance 188.8.131.52 Strategic Initiatives 6.1.3 Canopy Growth Corporation. 184.108.40.206 Company overview 220.127.116.11 Financial performance 18.104.22.168 Strategic Initiatives 6.1.4 HempMeds 22.214.171.124 Company overview 126.96.36.199 Strategic Initiatives 6.1.5 CV Sciences, Inc. 188.8.131.52 Company overview 184.108.40.206 Strategic Initiatives 6.1.6 ENDOCA 220.127.116.11 Company overview 6.1.7 Isodiol International, Inc. 18.104.22.168 Company overview 22.214.171.124 Strategic Initiatives 6.1.8 CBD Life 126.96.36.199 Company overview 188.8.131.52 Strategic initiatives 6.1.9 PharmaCielo 184.108.40.206 Company overview 220.127.116.11 Strategic initiatives 6.1.10 CBD American Shaman 18.104.22.168 Company overview 6.1.11 Elixinol 22.214.171.124 Company overview
Our library has over 100000 reports on 1000s of topics
Over 100+ Fortune 500 companies rely on us
90,000+ people come to us for insights every month
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.